We're downgrading it, considering the next step

Shares of Abbott Laboratories fell 3% on Wednesday after the diversified healthcare company turned in another less-than-stellar quarter. Revenue in…

This is the guide

ABBOTT Laboratories actions fell on Thursday after the diversified medical care company delivered a second solid quarter, but left investors…

We are lowering our target price of Bristol Myers despite a profit rate

Bristol Myers Squibb and Rosy Outlook's profits on Thursday did not solve persistent problems for actions. But it was enough,…